Andres Technology, in Chen Yang's positioning, is a company involving high-tech, cutting-edge biotechnology, although it is still in its infancy, but with a billion dollars of start-up capital, Fang Ye They directly in the downtown business district, a building rented a three-story building as the company's office location.

Of course, the real research center is just outside Los Angeles, in the same pharmaceutical factory that was being renovated and built.

"This is Glie. Dr. Foyle, Gordon. Dr. Freeman and Dagenham. Dr. Hills ......"

Everyone walked into the company's conference room, and the three hired doctors of biomedicine stood up together, and Fang Ye hurriedly introduced Chen Yang.

Chen Yang stretched out his hand and shook hands with the three doctors one after another.

In fact, these three doctors were selected by Chen Yang, so how could he not know these three people.

Glie. Dr. Foyle, 45 years old, used to work for Merck & Co., and was fired from the company because of a medical error, and is now at a low point in his life, divorced from his wife, and has not won custody of several children, and even his personal financial situation is embarrassing.

As a result, Andres was only a new company, but Foyle did not hesitate to agree to the generous remuneration.

The other two Dr. Freeman and Dr. Hills were both financially worried, and it was because of this that they had to agree to Andres's offer under great pressure from their lives.

In this world, it does not mean that talents can really be reused and use their talents, not to mention talents, even many geniuses have a series of deeply regrettable things for various reasons.

These three doctors all have certain talents, but unfortunately they are not very lucky. If it weren't for Chen Yang's fancy to them, it was likely that he would really waste his life.

"Three doctors, I'm glad you're able to accept an offer from our company."

Chen Yang spoke fluent English, and everyone present could hear it clearly except for Wang Rui, who was at a loss.

Sitting down on the chairman's seat, Chen Yang smiled slightly: "I know three doctors. In fact, I don't really want to accept the company's employment, thinking that we are just a new company with little technology, and here, I can tell the three doctors that in fact, the company is not without technology, but only has to turn technology into actual people. ”

After saying these words, Chen Yang gestured to Liu Helan with his eyes, Liu Helan nodded, took out the silver-white lockbox and opened it. He took out five copies of the text and handed them to everyone present.

"It's ......"

Foyle and the other three doctors took the text suspiciously and flipped through it casually.

The three of them just finished reading the content of one page, and the expression on their faces changed from the initial indifference to solemn and solemn, and the degree of their fingers flipping through the text suddenly slowed down, like a priest holding a Bible. Read it almost word for word.

Chen Yang was very patient, sipping the coffee on the table. Patiently waiting for the three doctors to read, without the slightest hint of impatience.

The three doctors of biomedicine could understand it, and Fang Ye and Feng Li's English was not good enough to scan through the full article of medical terms without any obstacles, and after quickly flipping through a few pages, they put it down dizzily.

Half an hour passed. The coffee was changed three times, and the three doctors finally finished reading the text.

After reading this, Dr. Foyle asked impatiently, "Where did all this information come from?" ”

"Where did it come from?"

Chen Yang didn't mind Foyle's distrust, and kept a smile and said: "I have already said before, the company is technical. It is not lagging behind the rest of the pharmaceutical companies, but what is lacking is just talents like three doctors. ”

He contradicts what he said, since there is a shortage of talent, where does the technology come from?

Since there is technology, then there is certainly no shortage of talent.

The three doctors only thought that Chen Yang was polite and didn't take it seriously, but what was said in this information, judging from their experience, the authenticity of these numbers was very large, and it was almost impossible to make it up, so they waited for the clinical trial to enter the FDA review.

"If all the information on this is true, no, it really can't be wrong, then the benefits are obvious."

"You should know that the President's Scientific and Technological Advisory Committee (PCAST) has recently established measures for the government to speed up the research on new antibiotics, and the FDA has established a special green fast track for the approval of this class of drugs to ensure that they can be marketed as much as possible. ”

"In this way, we will be able to seize the opportunity and get strong support from the government."

Antibiotics, the most famous representative of which is penicillin, have traveled for nearly a century since their birth in 1928 and have saved thousands of lives.

However, due to the massive abuse of antibiotics, the resistance of some bacteria has been increasing, and many antibiotics are no longer useful.

This situation has intensified since the 90s and has intensified in the past 20 years, making many biopharmaceutical companies prescribe new antibiotics far less than the time of bacterial resistance, resulting in research and development costs exceeding their means.

This status quo reached its peak in the late nineties and early twenty-first century, and many biomedical giants gave up the research and development of antibiotics.

But giving up research doesn't mean that bacterial resistance won't develop.

On the contrary, in recent years, many drug-resistant bacteria have increased dramatically, causing many diseases that were already under control to get out of control.

For example, conjugated bacilli have caused tuberculosis in many developing countries to tend to worsen.

If we don't pay attention to this problem, I believe that it will not take many years, and many doctors will be shocked to find that no matter how many units of antibiotics are, they will not have any effect on some levels of drug-resistant bacteria.

In that case, the mortality rate of human beings from diseases will be greatly increased.

So, in the context of this huge future crisis, which has also attracted the attention of the Obama administration, this will be a very big opportunity.

Generally speaking, the review process of a new drug takes seven or eight months, and even several years. This time, with the support of the Washington government, both the degree and the associated expenses will be reduced in large quantities.

These are not the most important things, catch up with the rest of the biomedical companies, get the government's approval, then you don't have to bother to advertise and go public relations promotion.

With the support of the government, think about it, how many hospitals are there in the United States? And what about the rest of the countries?

You must know that seven of the world's top 10 pharmaceutical companies are in the United States, and with the support of the government, it is more conducive to promoting new antibiotics in the rest of the countries.

Money, untold money.

Chen Yang pinched his finger on the table and said: "What Dr. Shears said is right, and I agree with this point, so we must grasp this opportunity, and the opportunity is urgent, we must launch our antibiotics before the rest of the pharmaceutical companies launch new antibiotics!" ”

Even with the heart of civilization and the right hand such a cheating tool, Chen Yang did not dare to ignore those multinational pharmaceutical companies, tens of thousands of researchers, the most advanced research equipment, the top biological talents, and the most abundant research funds, as long as they made up their minds and gathered strength, except for those unsolved terminal diseases, there were really not many difficulties that could hardly stop them.

Therefore, it is the most important thing to seize the time to produce new antibiotics and follow the approval of the government.

It was also the first step in making Andres' name known.

This research data gave Hills and the other three great confidence, eating and waiting for death and working hard, it was completely two mental states, since they knew that this new company was not simple, the hearts of the three of them were a lot more stable.

Although Fang Ye and Feng Li did not understand the knowledge of biomedicine, Chen Yang's discussion with the three doctors explained clearly enough, and they also knew the business opportunities and potentials contained in it.

As long as you get your hands on it, it's a big deal.

Andres had only $1.2 billion in start-up capital, of which $500 million would go to Australia and $700 million to North America.

It seems to be a huge number, but in fact, in terms of medical prescription, it is difficult to describe it as overstretched, and it can only be said to be a fart.

After the previous pharmaceutical company "Eli Lilly" invested more than one billion dollars to develop a new drug, it invested another 500 million dollars to continue to prescribe it, and the success rate of the new drug was only 9%.

$700 million to buy land, to buy land, to buy a small pharmaceutical factory, to build a few more office buildings, and to produce new drugs......

Chen Yang could imagine the scene where Fang Ye and Feng Li came together to ask for money a month later.

As for another chess piece, Tianqi Technology Company, although it is expected to make a profit of more than one billion dollars in the next year, the earliest amount of money, at most hundreds of millions of dollars, is still far from enough.

Thinking of this, Chen Yang frowned and said, "Dr. Foyle, how much do you think the annual sales of this new antibiotic can reach after it is launched?" ”

Although Foyle is a scientist, he has also worked at Merck, and he clearly knows the sales and potential of some new drugs, and when he heard Chen Yang's question, he lowered his head and thought for a while, and then raised his head and said: "According to the information on this article, this new antibiotic has a wide range of uses, and the annual sales potential should be between more than two billion dollars and three billion dollars." ”

Chen Yang nodded, this number is not a small number, for example, the well-known amoxicillin, which was first developed by the British Beechem Company, and the annual sales in the world market are only about 1.7 billion US dollars.

If you really have annual sales of more than two billion dollars, it is truly the king of antibiotics.

However, such a road is obviously also very long, and it is not so easy and smooth to complete. (To be continued......)

Tips: The new domain name "biquge.info" has been launched by Biquge, and the original domain name is about to be discontinued. Please tell each other, thank you!